GlassScriptPhysician profile
Katarzyna Zalewski
NPI 1871559294
$1,486.32
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $417 · 2021: $425 · 2022: $84.74 · 2024: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $492.24 | 2019-2021 | |
| Shockwave Medical, INC | $143.37 | 2021 | |
| Bard Peripheral Vascular, INC. | $143.32 | 2020 | |
| Bolton Medical INC | $140.32 | 2024 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $138.52 | 2021 | |
| Penumbra, INC. | $120.28 | 2024 | Indigo System |
| Merck Sharp & Dohme LLC | $100.47 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $60.45 | 2019-2022 | |
| Covidien LP | $48.10 | 2019 | |
| Boston Scientific Corporation | $32.95 | 2022 | |
| Mallinckrodt Hospital Products INC. | $30.21 | 2020 | |
| Mallinckrodt Enterprises LLC | $22.03 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katarzyna Zalewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.